Management of Non-Small Cell Lung Cancer: Updates from the European Lung Cancer Congress 2022.
Cancer Invest
; 40(7): 577-589, 2022 Aug.
Article
en En
| MEDLINE
| ID: mdl-35561313
ABSTRACT
The recently concluded European Lung Cancer Congress 2022 (ELCC22) showcased some very exciting data, with more than 200 abstracts presented during the meeting. Through this review, we focus on selected clinically relevant abstracts that in our opinion represent significant updates in the current management of non-small cell lung cancer (NSCLC). Here, we summarize the updates in surgical management, adjuvant therapy and therapy for advanced stage NSCLC and put these advances in the context of the current clinical standard of care.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Carcinoma de Pulmón de Células no Pequeñas
/
Neoplasias Pulmonares
Límite:
Humans
Idioma:
En
Revista:
Cancer Invest
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos